Also, the usage of PD-L1 CAR NK cells is made possible with this cell line, which is ready to be translated to clinical studies showing cytotoxic behavior against human head and neck squamous cell carcinoma in mice, demonstrating crosstalk with the adaptive immunity [24]. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.